Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
Graphique 1 - Faculté de Médecine et de Pharmacie de Fès
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
72. Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GR.<br />
Thrombocytopenia in SLE and related autoimmune disor<strong>de</strong>rs: Association<br />
with anticardiolipin antibody. Br J Haematol 1985;59:227-30.<br />
73. Zhao H, Li S, and Yang R. Thrombocytopenia in patients with systemic lupus<br />
erythematosus: significant in the clinical implication and prognosis. Platel<strong>et</strong>s,<br />
August 2010;21(5):380-385.<br />
74. Rabbani MA, Ahmad B, Mekan SF, Muzaffar S, Ali SS. Systemic lupus erythematosus<br />
presenting as hemolytic uremic syndrome: a case report. Pak Med Assoc. 2005<br />
Feb;55(2):84-7.<br />
75. Kaplan C, Champeix P, Blanchard D, Muller JY, Cartron JP. Platel<strong>et</strong> antibodies in<br />
systemic lupus erythematosus. Br J Haematol 1987 ;67 :89-93.<br />
76. Cooper N, Bussel J: The pathogenesis of immune thrombocytopenic purpura. Br J<br />
Haematol 2006; 133(4): 364-74.<br />
77. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nur<strong>de</strong>n P, Leng B, Nur<strong>de</strong>n AT.<br />
Anti-platel<strong>et</strong> antibodies in patients with systemic lupus erythematosus and the<br />
primary antiphospholipid antibody syndrome: Their relationship with the observed<br />
thrombocytopenia. Br J Haematol 1997;98:336-341.<br />
78. Firkin BG, Buchanan RRC, Pfueller S, <strong>et</strong> al. Lupoid thrombocytopenia. Aust NZ J Med<br />
1987;17:295–300.<br />
79. An<strong>de</strong>rson MJ, Peebles CL, McMillar R, <strong>et</strong> al. Fluorescent antinuclear antibodies<br />
and anti-SSA/Ro in patients with immune thrombocytopenia <strong>de</strong>veloping<br />
systemic lupus erythematosus. Ann Intern Med 1985;103:548–551.<br />
80. Morley KD, Bernstein RM, Bunn CC, <strong>et</strong> al. Thrombocytopenia and anti-Ro.<br />
Lanc<strong>et</strong> 1981;2:940.<br />
81. Niaz FA, Aamer A. Response to Rituximab in a refractory Case of thrombotic<br />
thrombocytopenic purpura associated with systemic lupus erythematosus.<br />
Saudi J Kidney Dis Transpl 2010;21(1):109-112.<br />
82. Bianchi V, Robles R, Alberio L, Furlan M, Lammle B. Von Willibrand factorcleaving<br />
protease (ADAMTS 13) in thrombocytopenic disor<strong>de</strong>rs: a severely<br />
<strong>de</strong>ficient activity is specific for thrombotic thrombocytopenic purpura. Blood<br />
2002;100:710-3.<br />
83. Ruggenenti P, Noris M, Remuzzi G.Thrombotic microangiopathy, hemolytic<br />
uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int<br />
2001;60:831.<br />
84. Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated<br />
with systemic lupus erythematosus. Acta Haematol 2006;115(1-2):68-73.<br />
85. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of<br />
thrombotic thrombocytopenic purpura. J.Am Soc Nephrol 2003;14:1072.<br />
199
Change language